How does the appointment of a common representative affect existing appointments in a PCT application?

The appointment of a common representative in a PCT application has specific effects on existing appointments: It automatically revokes any earlier appointment of a common representative, unless otherwise indicated. This revocation is immediate upon the new appointment being made. According to MPEP 1808: “The appointment of a common representative similarly has the effect, unless otherwise…

Read More

How does the clarity of claims affect the international search and examination process?

The clarity of claims plays a crucial role in the international search and examination process under the Patent Cooperation Treaty (PCT). MPEP 1843.03 highlights this importance: “If the International Searching Authority considers that the description, claims, or drawings are so unclear, or the claims are so inadequately supported by the description that no meaningful opinion…

Read More

How can a U.S. national stage application claim benefit under 35 U.S.C. 119(e) of a prior U.S. provisional application?

To claim benefit under 35 U.S.C. 119(e) of a prior U.S. provisional application in a national stage application, the following requirements must be met: The national stage application must comply with 37 CFR 1.78(a). The provisional application must have a filing date and the basic filing fee must have been paid within the specified time…

Read More

How can a U.S. national stage application claim benefit under 35 U.S.C. 120 and 365(c) of a prior application?

To claim benefit under 35 U.S.C. 120 and 365(c) of a prior filed copending nonprovisional application or prior filed copending international application designating the United States, the national stage application must meet these requirements: Comply with 37 CFR 1.78(d). The prior application must name at least one inventor also named in the later filed international…

Read More

What should applicants consider when choosing an International Searching Authority?

When choosing an International Searching Authority (ISA), applicants should carefully consider the subject matter of their invention and the search policies of different ISAs. The MPEP 1843.02 advises: “The applicant considering the filing of an international application may be well advised not to file one if the subject matter of the application falls into one…

Read More

How should chemical formulae be included in a PCT application abstract?

When including chemical formulae in a PCT application abstract, follow these guidelines: Include the chemical formula that best characterizes the invention. Choose the most characteristic formula among all formulae contained in the application. MPEP 1826 states: “Where applicable, the chemical formula which, among all the formulae contained in the international application, best characterizes the invention.”…

Read More

How is the certified copy of the priority document handled in a U.S. national stage application?

The certified copy of the priority document in a U.S. national stage application is typically handled through the International Bureau. According to the MPEP: “Where applicant has complied with PCT Rule 17, the International Bureau will forward a copy of the certified priority document to each Designated Office that has requested such document with an…

Read More

Can a Certificate of Transmission be used for facsimile submissions in international patent applications?

The use of a Certificate of Transmission for facsimile submissions in international patent applications is limited. According to the MPEP section 1834.01: “A Certificate of Transmission may be used as provided in 37 CFR 1.8(a)(1) except in the instances specifically excluded in 37 CFR 1.8(a)(2).” However, it’s crucial to note the following restriction: “Note particularly…

Read More